404: Page not Found
To find an doctor profile, first select a location from the home page and then search.
If you can't find the page you're looking for using the navigation above, please Contact Us.
To find an doctor profile, first select a location from the home page and then search.
If you can't find the page you're looking for using the navigation above, please Contact Us.
In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.
Articles From the Agency for Healthcare and Quality (AHRQ) by Dr. Carolyn Clancy, Director
Introducing Peanut in Infancy Prevents Peanut Allergy into Adolescence
Feeding children peanut products regularly from infancy to age 5 years reduced the rate of peanut allergy in adolescence by 71%, even when the children ate or avoided peanut products as desired for many years.
AMA statement on second COVID-19 bivalent vaccine booster dose
“Now that a second bivalent booster dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines is available to adults 65 years of age and older as well as people who are immunocompromised and at high-risk of severe outcomes from COVID-19, the AMA encourages everyone who is eligible to get their second booster dose.
The Rules for Measuring Blood Pressure – and Why They Exist
The last time your blood pressure was measured, did you rush to the appointment while sipping coffee? Were you perched on an exam table with your legs dangling or your arm hanging? Were you chatting with a medical staff member or scrolling social media on your phone? Was your bladder full?
FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
The U.S. Food and Drug Administration today cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s disease. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in adult patients, aged 55 years and older, exhibiting signs and symptoms of the disease.
Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.
Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.